Survival and Response After Peptide Receptor Radionuclide Therapy With [90Y-DOTA0,Tyr3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

Roelf Valkema, Eric P. Krenning, Larry K. Kvols et al.|Seminars in Nuclear Medicine|2006

Cited by 313